Cyclosporine A prevents neurological deterioration of patients with SAH--a preliminary report.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 1763680.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the present study we found that the neurological outcome in patients anaesthetized for early clipping (up to 72 h after SAH) of a ruptured aneurysm and treated with cyclosporine A was significantly better than the neurological state of control patients without immuno-suppressive treatment. The results justify the presumption that auto-immune reactions are involved in the deterioration of the postoperative neurological state of patients with SAH after rupture of an intracranial aneurysm. Supplementing a standard surgical and pharmacological treatment with cyclosporine A seems to reduce the undesirable neurological consequences of the immunologically, induced vascular disturbance after SAH.
Medical subject headings
- Autoimmune Diseases
- Cyclosporine
- Intracranial Aneurysm
- Ischemic Attack, Transient
- Postoperative Complications
- Subarachnoid Hemorrhage